Comparative study evaluating efficacy of sufentanil versus midazolam in preventing myoclonic movements following etomidate

BACKGROUND AND AIMS: Myoclonus is a major side-effect following etomidate injection requiring use of medical intervention. MATERIAL AND METHODS: In this double-blinded clinical trial, 50 consecutive patients, randomly received sufentanil 0.2 μg/kg or midazolam 0.015 mg/kg, 90 s before induction of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Alipour, Mohammad, Tabari, Masoumeh, Azad, Azadeh Mokhtari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784209/
https://www.ncbi.nlm.nih.gov/pubmed/27006537
http://dx.doi.org/10.4103/0970-9185.173382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784209/
https://www.ncbi.nlm.nih.gov/pubmed/27006537
http://dx.doi.org/10.4103/0970-9185.173382

Ejemplares similares